 ?您的位置：對(duì)照品 > 對(duì)照品 > 中藥對(duì)照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：R700975 |
| 產(chǎn)品名稱：RP 5264 |
| 產(chǎn)品CAS：1532533-67-7 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
R700975 |
| 名稱: |
RP 5264 |
| 別名: |
2-[(1S)-1-[4-Amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one; TGR 1202 |
| CAS號(hào): |
1532533-67-7 |
| 分子式: |
C??H??F?N?O? |
| 分子量: |
571.55 |
| 類別: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
RP 5264 is a novel PI3K inhibitor that enhances Brentuximab Vedotin-induced lymphoma cell death. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
